A Polygenic Risk Score of glutamatergic SNPs associated with schizophrenia predicts attentional behavior and related brain activity in healthy humans

Antonio Rampino, Paolo Taurisano, Giuseppe Fanelli, Mariateresa Attrotto, Silvia Torretta, Linda Antonella Antonucci, Grazia Miccolis, Giulio Pergola, Gianluca Ursini, Giancarlo Maddalena, Raffaella Romano, Rita Masellis, Pasquale Di Carlo, Patrizia Pignataro, Giuseppe Blasi, Alessandro Bertolino

Research output: Contribution to journalArticle

Abstract

Multiple genetic variations impact on risk for schizophrenia. Recent analyses by the Psychiatric Genomics Consortium (PGC2) identified 128 SNPs genome-wide associated with the disorder. Furthermore, attention and working memory deficits are core features of schizophrenia, are heritable and have been associated with variation in glutamatergic neurotransmission. Based on this evidence, in a sample of healthy volunteers, we used SNPs associated with schizophrenia in PGC2 to construct a Polygenic-Risk-Score (PRS) reflecting the cumulative risk for schizophrenia, along with a Polygenic-Risk-Score including only SNPs related to genes implicated in glutamatergic signaling (Glu-PRS). We performed Factor Analysis for dimension reduction of indices of cognitive performance. Furthermore, both PRS and Glu-PRS were used as predictors of cognitive functioning in the domains of Attention, Speed of Processing and Working Memory. The association of the Glu-PRS on brain activity during the Variable Attention Control (VAC) task was also explored. Finally, in a second independent sample of healthy volunteers we sought to confirm the association between the Glu-PRS and both performance in the domain of Attention and brain activity during the VAC.We found that performance in Speed of Processing and Working Memory was not associated with any of the Polygenic-Risk-Scores. The Glu-PRS, but not the PRS was associated with Attention and brain activity during the VAC. The specific effects of Glu-PRS on Attention and brain activity during the VAC were also confirmed in the replication sample.Our results suggest a pathway specificity in the relationship between genetic risk for schizophrenia, the associated cognitive dysfunction and related brain processing.

Original languageEnglish (US)
Pages (from-to)928-939
Number of pages12
JournalEuropean Neuropsychopharmacology
Volume27
Issue number9
DOIs
StatePublished - Sep 1 2017

Fingerprint

Single Nucleotide Polymorphism
Schizophrenia
Brain
Short-Term Memory
Healthy Volunteers
Memory Disorders
Genomics
Synaptic Transmission
Statistical Factor Analysis
Psychiatry
Genome

Keywords

  • Attention
  • Cortex
  • Glutamate
  • Prefrontal
  • Schizophrenia
  • Working memory

ASJC Scopus subject areas

  • Pharmacology
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Pharmacology (medical)

Cite this

A Polygenic Risk Score of glutamatergic SNPs associated with schizophrenia predicts attentional behavior and related brain activity in healthy humans. / Rampino, Antonio; Taurisano, Paolo; Fanelli, Giuseppe; Attrotto, Mariateresa; Torretta, Silvia; Antonucci, Linda Antonella; Miccolis, Grazia; Pergola, Giulio; Ursini, Gianluca; Maddalena, Giancarlo; Romano, Raffaella; Masellis, Rita; Di Carlo, Pasquale; Pignataro, Patrizia; Blasi, Giuseppe; Bertolino, Alessandro.

In: European Neuropsychopharmacology, Vol. 27, No. 9, 01.09.2017, p. 928-939.

Research output: Contribution to journalArticle

Rampino, A, Taurisano, P, Fanelli, G, Attrotto, M, Torretta, S, Antonucci, LA, Miccolis, G, Pergola, G, Ursini, G, Maddalena, G, Romano, R, Masellis, R, Di Carlo, P, Pignataro, P, Blasi, G & Bertolino, A 2017, 'A Polygenic Risk Score of glutamatergic SNPs associated with schizophrenia predicts attentional behavior and related brain activity in healthy humans', European Neuropsychopharmacology, vol. 27, no. 9, pp. 928-939. https://doi.org/10.1016/j.euroneuro.2017.06.005
Rampino, Antonio ; Taurisano, Paolo ; Fanelli, Giuseppe ; Attrotto, Mariateresa ; Torretta, Silvia ; Antonucci, Linda Antonella ; Miccolis, Grazia ; Pergola, Giulio ; Ursini, Gianluca ; Maddalena, Giancarlo ; Romano, Raffaella ; Masellis, Rita ; Di Carlo, Pasquale ; Pignataro, Patrizia ; Blasi, Giuseppe ; Bertolino, Alessandro. / A Polygenic Risk Score of glutamatergic SNPs associated with schizophrenia predicts attentional behavior and related brain activity in healthy humans. In: European Neuropsychopharmacology. 2017 ; Vol. 27, No. 9. pp. 928-939.
@article{b8fc8a129bcb4a84a75b3eb45171837a,
title = "A Polygenic Risk Score of glutamatergic SNPs associated with schizophrenia predicts attentional behavior and related brain activity in healthy humans",
abstract = "Multiple genetic variations impact on risk for schizophrenia. Recent analyses by the Psychiatric Genomics Consortium (PGC2) identified 128 SNPs genome-wide associated with the disorder. Furthermore, attention and working memory deficits are core features of schizophrenia, are heritable and have been associated with variation in glutamatergic neurotransmission. Based on this evidence, in a sample of healthy volunteers, we used SNPs associated with schizophrenia in PGC2 to construct a Polygenic-Risk-Score (PRS) reflecting the cumulative risk for schizophrenia, along with a Polygenic-Risk-Score including only SNPs related to genes implicated in glutamatergic signaling (Glu-PRS). We performed Factor Analysis for dimension reduction of indices of cognitive performance. Furthermore, both PRS and Glu-PRS were used as predictors of cognitive functioning in the domains of Attention, Speed of Processing and Working Memory. The association of the Glu-PRS on brain activity during the Variable Attention Control (VAC) task was also explored. Finally, in a second independent sample of healthy volunteers we sought to confirm the association between the Glu-PRS and both performance in the domain of Attention and brain activity during the VAC.We found that performance in Speed of Processing and Working Memory was not associated with any of the Polygenic-Risk-Scores. The Glu-PRS, but not the PRS was associated with Attention and brain activity during the VAC. The specific effects of Glu-PRS on Attention and brain activity during the VAC were also confirmed in the replication sample.Our results suggest a pathway specificity in the relationship between genetic risk for schizophrenia, the associated cognitive dysfunction and related brain processing.",
keywords = "Attention, Cortex, Glutamate, Prefrontal, Schizophrenia, Working memory",
author = "Antonio Rampino and Paolo Taurisano and Giuseppe Fanelli and Mariateresa Attrotto and Silvia Torretta and Antonucci, {Linda Antonella} and Grazia Miccolis and Giulio Pergola and Gianluca Ursini and Giancarlo Maddalena and Raffaella Romano and Rita Masellis and {Di Carlo}, Pasquale and Patrizia Pignataro and Giuseppe Blasi and Alessandro Bertolino",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.euroneuro.2017.06.005",
language = "English (US)",
volume = "27",
pages = "928--939",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier",
number = "9",

}

TY - JOUR

T1 - A Polygenic Risk Score of glutamatergic SNPs associated with schizophrenia predicts attentional behavior and related brain activity in healthy humans

AU - Rampino, Antonio

AU - Taurisano, Paolo

AU - Fanelli, Giuseppe

AU - Attrotto, Mariateresa

AU - Torretta, Silvia

AU - Antonucci, Linda Antonella

AU - Miccolis, Grazia

AU - Pergola, Giulio

AU - Ursini, Gianluca

AU - Maddalena, Giancarlo

AU - Romano, Raffaella

AU - Masellis, Rita

AU - Di Carlo, Pasquale

AU - Pignataro, Patrizia

AU - Blasi, Giuseppe

AU - Bertolino, Alessandro

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Multiple genetic variations impact on risk for schizophrenia. Recent analyses by the Psychiatric Genomics Consortium (PGC2) identified 128 SNPs genome-wide associated with the disorder. Furthermore, attention and working memory deficits are core features of schizophrenia, are heritable and have been associated with variation in glutamatergic neurotransmission. Based on this evidence, in a sample of healthy volunteers, we used SNPs associated with schizophrenia in PGC2 to construct a Polygenic-Risk-Score (PRS) reflecting the cumulative risk for schizophrenia, along with a Polygenic-Risk-Score including only SNPs related to genes implicated in glutamatergic signaling (Glu-PRS). We performed Factor Analysis for dimension reduction of indices of cognitive performance. Furthermore, both PRS and Glu-PRS were used as predictors of cognitive functioning in the domains of Attention, Speed of Processing and Working Memory. The association of the Glu-PRS on brain activity during the Variable Attention Control (VAC) task was also explored. Finally, in a second independent sample of healthy volunteers we sought to confirm the association between the Glu-PRS and both performance in the domain of Attention and brain activity during the VAC.We found that performance in Speed of Processing and Working Memory was not associated with any of the Polygenic-Risk-Scores. The Glu-PRS, but not the PRS was associated with Attention and brain activity during the VAC. The specific effects of Glu-PRS on Attention and brain activity during the VAC were also confirmed in the replication sample.Our results suggest a pathway specificity in the relationship between genetic risk for schizophrenia, the associated cognitive dysfunction and related brain processing.

AB - Multiple genetic variations impact on risk for schizophrenia. Recent analyses by the Psychiatric Genomics Consortium (PGC2) identified 128 SNPs genome-wide associated with the disorder. Furthermore, attention and working memory deficits are core features of schizophrenia, are heritable and have been associated with variation in glutamatergic neurotransmission. Based on this evidence, in a sample of healthy volunteers, we used SNPs associated with schizophrenia in PGC2 to construct a Polygenic-Risk-Score (PRS) reflecting the cumulative risk for schizophrenia, along with a Polygenic-Risk-Score including only SNPs related to genes implicated in glutamatergic signaling (Glu-PRS). We performed Factor Analysis for dimension reduction of indices of cognitive performance. Furthermore, both PRS and Glu-PRS were used as predictors of cognitive functioning in the domains of Attention, Speed of Processing and Working Memory. The association of the Glu-PRS on brain activity during the Variable Attention Control (VAC) task was also explored. Finally, in a second independent sample of healthy volunteers we sought to confirm the association between the Glu-PRS and both performance in the domain of Attention and brain activity during the VAC.We found that performance in Speed of Processing and Working Memory was not associated with any of the Polygenic-Risk-Scores. The Glu-PRS, but not the PRS was associated with Attention and brain activity during the VAC. The specific effects of Glu-PRS on Attention and brain activity during the VAC were also confirmed in the replication sample.Our results suggest a pathway specificity in the relationship between genetic risk for schizophrenia, the associated cognitive dysfunction and related brain processing.

KW - Attention

KW - Cortex

KW - Glutamate

KW - Prefrontal

KW - Schizophrenia

KW - Working memory

UR - http://www.scopus.com/inward/record.url?scp=85021241209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021241209&partnerID=8YFLogxK

U2 - 10.1016/j.euroneuro.2017.06.005

DO - 10.1016/j.euroneuro.2017.06.005

M3 - Article

C2 - 28651857

AN - SCOPUS:85021241209

VL - 27

SP - 928

EP - 939

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

SN - 0924-977X

IS - 9

ER -